Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Response to Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies Kremer, J., Dougados, M., Genovese, M. C., Emery, P., Yang, L., de Bono, S., Holzkaemper, T., Iikuni, N., Schlichting, D. E., Smolen, J. S. WILEY-BLACKWELL. 2015
View details for Web of Science ID 000370860202314